Skip to main content
. 2022 Feb 28;14:834114. doi: 10.3389/fnagi.2022.834114

TABLE 1.

Baseline characteristics of the recruited patients.

Characteristics* CI-E nCI-E P
No. of subjects 105 (56.1) 82 (43.9)
Demographics
Age, y 59 (13) 54 (16) 0.001
Female 27 (25.7) 12 (14.6) 0.064
Education, y 7 (3) 8 (2) 0.000
Cigarette smoking 55 (52.4) 47 (57.3) 0.501
Alcohol drinking 23 (21.9) 29 (35.4) 0.041
Medical histories
History of hypertension 69 (65.7) 58 (70.7) 0.466
History of hyperlipidemia 38 (36.2) 29 (35.4) 0.907
History of diabetes 43 (41.0) 23 (28.0) 0.067
History of stroke 55 (52.4) 47 (46.1) 0.501
Clinical features
BMI, kg/m2 24.2 (4.2) 24.3 (4.2) 0.722
Baseline NIHSS score 2 (4) 2 (2) 0.859
Baseline BI 80 (35) 85 (35) 0.517
Infarcted location (Cortical infarct) 33 (31.4) 29 (35.4) 0.570
Stroke causes (LAA) 65 (61.9) 43 (52.4) 0.193
Baseline laboratory findings
WBC, ×109/L 7.6 (2.8) 7.8 (3.1) 0.799
NEU, ×109/L 5.0 (2.2) 4.6 (2.8) 0.459
LYM, ×109/L 2.0 (0.9) 1.9 (1.2) 0.909
ESR, mm/h 10 (12) 6 (9) 0.000
IL-6, pg/mL 3.54 (3.91) 2.65 (2.63) 0.001
CRP, mg/L 1.37 (2.48) 0.90 (2.50) 0.044
Cognitive scores within 2 weeks
MMSE 24 (5) 28 (2) <0.001
MoCA 16 (7) 24 (3) <0.001

*Continuous variables are expressed as median (IQR). Categorical variables are expressed as frequencies (percentages).

CI-E, early cognitive impairment after stroke; nCI-E, non-early cognitive impairment after stroke; LAA, large-artery atherosclerosis; WBC, white blood cells count; NEU, neutrophil count; LYM, lymphocyte count; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; IL-6, interleukin-6.